2021 mAbTalk symposium

New Horizon of Antibody Drug Conjugate (ADC)

May 22, 2021, 8 p.m. (US EDT) | May 23, 2021, 8 a.m. (Beijing)

Live on Zoom, Free for Everyone

Login to view recordings

Overview

Antibody-drug conjugate (ADC) leverages the benefits of the high specificity from monoclonal antibody drugs and the high potency from small-molecule drugs to improve efficiency with reduced side-effects. Up to date, 11 ADC drugs have been approved by US FDA for marketing; 90 ADC drugs are in the clinical stage; and more than 200 are under discovery and preclinical development. Although ADC drugs have achieved impressive clinical outcome, there are still many challenges to overcome, such as toxic side effects, lack of biomarkers for screening patients, and development of drug resistance. Discovery of novel targets, conjugation technologies, and new payload modalities opens a new era of ADC therapeutics development.

Chinese Antibody Society (CAS) is pleased to continue hosting mAbTalks series in 2021 - “New Horizon of Antibody-Drug Conjugate (ADC)” virtual symposium. The symposium will be held online via Zoom and free for registration. In our half-day event, speakers from both industry and academia will share their insights in diverse topics of ADC-based therapeutics, including discovery & new techniques, clinical development strategies, and CMC. Dr. Daotian Fu, President of RemeGen, Co., Ltd., and a board member of CAS, will be the symposium chair. This event is a perfect opportunity for the attendees to stay up to date on the most recent progress and challenges in ADC-based drug development. We have invited distinguished guest speakers in biopharma industry and academia specializing in ADC-based drug development. Online LIVE Q & A sessions will be included after every presentation. We sincerely invite you to join us online on May 22, 2021 evening (US EST)/May 23, 2021 morning (Beijing Time), enjoying the cutting-edge science and direct communications with ADC experts in the field.

Coincident with this ADC symposium, CAS’ official journal, Antibody Therapeuticspublished by Oxford University Press is organizing a special issue with focus upon “Antibody-targeted Cytotoxic agents – Immunotoxins and ADCs”. You are welcome to click here if you’d like to make contribution.

Sponsors

Platinum

Gold

Silver

Speakers

Hover above speaker cards to read bio

bio

Daotian Fu, PhD

President, RemeGen

bio

Christoph Rader, PhD

Associate Dean, The Scripps Research Institute

bio

Xinfang Li, PhD

President, MabPlex

bio

Kyoji Tsuchikama, PhD

Assistant Professor, The University of Texas Health Science Center at Houston

bio

Yongxin Zhao, PhD

President, DAC Biotech

bio

Shan Jiang, PhD

Executive Director, Pharmaceutical Sciences, Seagen Inc.

bio

Jacqueline Ming Liu, MD

Chief Medical Officer, TOT Biopharm

Agenda

Starts at 05/22/2021 8 p.m. (US EDT) | 05/23/2021 8 a.m. (Beijing)

Hover to view abstract

05/22/2021 8 p.m. EDT

Introduction to Chinese Antibody Society and mAbTalk

Daotian Fu, PhD, President, RemeGen

05/22/2021 8:10 p.m. EDT

Next-Generation Antibody-Drug Conjugates

Christoph Rader, PhD, Associate Dean, The Scripps Research Institute

05/22/2021 8:40 p.m. EDT

A novel ADC platform and the ADCs generated from the platform in the targeted treatment of cancer

Yongxin Zhao, PhD, President, DAC Biotech

05/22/2021 9:10 p.m. EDT

Novel Linker Technologies for Generating ADCs for Cancer Therapy

Kyoji Tsuchikama, PhD, Assistant Professor, The University of Texas Health Science Center at Houston

05/22/2021 9:40 p.m. EDT

Break

Organizer, , The Chinese Antibody Society

05/22/2021 10:10 p.m. EDT

Advancing ADCs for Transformative Cancer Therapies

Shan Jiang, PhD, Executive Director, Pharmaceutical Sciences, Seagen Inc.

05/22/2021 10:40 p.m. EDT

Challenges in the Clinical Development of Antibody Drug Conjugates

Jacqueline Ming Liu, MD, Chief Medical Officer, TOT Biopharm

05/22/2021 11:10 p.m. EDT

ADC Product Quality Development and Control

Xinfang Li, PhD, President, MabPlex

FAQ of Meeting Registration

If you have any questions, feel free to reach out to us
Yes! It's free for both CAS members and non-members
1. Click on the registration button at the top of the page, then answer a few simple questions to register

2. You will receive a Zoom invitation link in the email that you can use to connect to the event
Yes! Zoom is available for users outside of U.S., including China and Europe
We will be hosting a WeChat group for all attendees. Scan QR code to join 微信群1, or 微信群2
If you have joined our WeChat group for attendees, the easiest way to get a response is to post your question there. Otherwise, send us an email at conference@chineseantibody.org
This web app is a Python Django project independently coded (frontend+backend+deployment on AWS) by Xin Yu (Github, LinkedIn) in her volunteer capacity at the Chinese Antibody Society. Contents are maintained by CAS IT team. If you're interested in participating in the future development of this web app, please submit a volunteer application and request an interview with the IT team. We require a minimum of 2 years experience as a Django developer. © Chinese Antibody Society 2021. All Rights Reserved. Legal Disclaimer
Icon